Cite

HARVARD Citation

    Askeland, F. et al. (n.d.). P888: REPLACING STEROIDS IN TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: THE PHASE 2 ISATUXIMAB-BORTEZOMIB-LENALIDOMIDE-DEXAMETHASONE REST STUDY. HemaSphere. pp. 780-781. [Online]. 
  
Back to record